Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C: Relationship to interferon reponse
- 31 March 1997
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 26 (3), 574-583
- https://doi.org/10.1016/s0168-8278(97)80423-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alphaJournal of Hepatology, 1995
- Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trialHepatology, 1995
- Serum collagenase activity in patients with chronic liver diseaseJournal of Hepatology, 1993
- Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-βHepatology, 1993
- Cellular Sources of Collagen and Regulation of Collagen Production in LiverSeminars in Liver Disease, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagenBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosisLife Sciences, 1982